Related by context. Frequent words. (Click for all words.) 67 Panzem R 64 anticancer compound 64 KNS # 63 IND enabling 63 orally bioavailable 63 Atiprimod 63 elotuzumab 62 BiTE antibody 62 Cloretazine R VNP#M 62 ICA # 61 MAXY G# 61 Chemokine Therapeutics 61 CYC# 61 BCX# 61 Sym# 61 tanespimycin 61 Veronate 61 MEK inhibitor 61 non alcoholic steatohepatitis 61 epothilone 61 Onalta 61 rNAPc2 61 Diamyd ® 61 ACHN 61 active cellular immunotherapy 61 Voreloxin 61 registrational trial 60 Synavive 60 ApoB SNALP 60 GLPG# 60 Allovectin 7 R 60 IND submission 60 CR# vcMMAE 60 Menerba 60 Naproxcinod 60 Phase IIa clinical trials 60 novel anticancer 60 phase IIb 60 thymalfasin 59 NEUMUNE 59 Lu AA# 59 Carfilzomib 59 ALN TTR# 59 HGS ETR1 59 cangrelor 59 TELCYTA 59 phase IIa 59 HCV protease inhibitor 59 romidepsin 59 humanized antibody 59 talactoferrin 59 Traficet EN 59 bafetinib 59 Phase 2a clinical 59 MAP# 59 L Annamycin 59 ATL# [001] 59 CCX# 59 MOZOBIL 58 humanized anti 58 Phase Ib clinical 58 carcinoid syndrome 58 sodium Injection 58 Metastatic Melanoma 58 glufosfamide 58 KRN# 58 Pivotal Phase III 58 preclinical toxicology 58 preclinical 58 confirmatory Phase III 58 luteinizing hormone releasing 58 SinuNase 58 RGB # 58 EZN 58 HspE7 58 GSK # 58 BAY #-# 58 OncoVEX GM CSF 58 PRX # 58 Phase IIa trial 58 brostallicin 58 IMGN# 58 Asentar 58 mTOR inhibitor 57 OXi# 57 humanized monoclonal antibody 57 Phase 1b clinical 57 Protectan CBLB# 57 Phase IIa clinical 57 Omigard 57 pertuzumab 57 immunotherapeutic 57 Desmoteplase 57 Clavis Pharma 57 ALN VSP 57 Azixa 57 ocrelizumab 57 TOCOSOL Paclitaxel 57 AVN# [001] 57 outlicense 57 Zerenex